Co-Authors
This is a "connection" page, showing publications co-authored by Torsten Feldt and Johannes Fischer.
Connection Strength
1.035
-
Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing. Eur J Med Res. 2021 Aug 06; 26(1):87.
Score: 0.240
-
Correction to: The role of passive immunization in the age of SARS-CoV-2: an update. Eur J Med Res. 2020 Oct 30; 25(1):53.
Score: 0.228
-
The role of passive immunization in the age of SARS-CoV-2: an update. Eur J Med Res. 2020 May 13; 25(1):16.
Score: 0.220
-
Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reaction. Eur J Med Res. 2021 Aug 25; 26(1):98.
Score: 0.060
-
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 May 17; 22(1):343.
Score: 0.059
-
Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure. Front Immunol. 2021; 12:645989.
Score: 0.059
-
Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland. Strahlenther Onkol. 2020 12; 196(12):1068-1079.
Score: 0.056
-
Face masks: benefits and risks during the COVID-19 crisis. Eur J Med Res. 2020 Aug 12; 25(1):32.
Score: 0.056
-
The history and value of face masks. Eur J Med Res. 2020 Jun 23; 25(1):23.
Score: 0.056